Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
NCT02659618 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2022-02-11
Summary
The goal of this study is to identify a serum biomarker(s) that can detect increased levels of a population of CD15+ hypodense neutrophils termed low-density granulocytes (LDG) in the blood of patients with severe persistent asthma.
Conditions
- Severe Persistent Asthma
Sponsors & Collaborators
-
Genentech, Inc.
collaborator INDUSTRY -
Rush University Medical Center
lead OTHER
Eligibility
- Min Age
- 12 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2018-09-26
- Completion
- 2020-12-16
Countries
- United States
Study Locations
More Related Trials
-
Phenotypic and Functional Characterization of Neutrophils and Eosinophils in Severe Asthma Treated With Biotherapy
NCT05972213 ·Status: RECRUITING
-
Immune Interactions in Severe Asthma
NCT02566668 ·Status: COMPLETED
-
Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics
NCT01420003 ·Status: COMPLETED ·Phase: NA
-
Glasgow Asthma and Allergy Study
NCT01618318 ·Status: COMPLETED
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
NCT01589198 ·Status: COMPLETED
-
Asthma Biomarker Study
NCT02392481 ·Status: COMPLETED
-
Role of T-Cells in Asthma
NCT00001408 ·Status: COMPLETED
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma
NCT00725582 ·Status: COMPLETED ·Phase: PHASE1
-
Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.
NCT00339703 ·Status: COMPLETED
-
Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma
NCT00700726 ·Status: COMPLETED
-
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
NCT06015256 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma
NCT00507130 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED
-
Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma
NCT00267202 ·Status: COMPLETED ·Phase: PHASE4
-
An Investigation of Tumor Necrosis Factor (TNF)-Alpha in Asthma Using Biopsy Explants and Primary Bronchial Epithelial Cell Cultures
NCT01161303 ·Status: COMPLETED
-
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
NCT06621056 ·Status: RECRUITING
-
Intense Airway Eosinophilia in Asthma
NCT03696914 ·Status: COMPLETED
-
Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma
NCT00870584 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
NCT01334853 ·Status: COMPLETED
-
IL13 Signaling in Allergic Asthma
NCT05478824 ·Status: COMPLETED
-
Minimally Invasive Biomarker for Asthma Disease Severity
NCT02225678 ·Status: COMPLETED
-
Study of T-Regulatory Cells in Asthma
NCT02574351 ·Status: COMPLETED
-
Retrospective Cohort Study on Asthma With Frequent Acute Attacks Phenotype
NCT06026462 ·Status: NOT_YET_RECRUITING